Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GeneBioHealth

Request full access

A biotechnology company focusing on In Vitro Diagnostics (IVD) and human health

Shenzhen, ChinaFounded 2013Biotech & Life Sciences

About GeneBioHealth

Based in Shenzhen, China, GeneBioHealth operates within the diagnostic equipment sector, focusing on the development and provision of medical diagnostic products and services. The company was founded in 2013 and has since established itself as a venture capital-backed entity in the life sciences and oncology verticals.

The firm's core business revolves around in-vitro diagnostic technology and molecular biology research. Its product and service portfolio includes diagnostic technology, reagents, and instruments. These offerings cater to several critical areas of medical diagnosis, including tumor diagnosis, human leukocyte antigen (HLA) typing, and point-of-care testing (POCT), enabling healthcare providers to diagnose major diseases at an early stage. A notable product developed in collaboration with a research team from the Chinese University of Hong Kong is the REColonTMmiR-92a Assay Kit, designed for the early screening of colorectal cancer. This product targets the miRNA-92a marker, selected for its stability, high detection sensitivity, and specificity in colon cancer.

GeneBioHealth's business model is centered on the research, development, and sale of these diagnostic solutions to users in the medical industry. The company is in a revenue-generating stage, supported by significant investment. A key financial milestone was a Series B1 funding round on October 18, 2020, which raised $15 million. This round was led by BOC Guangdong Finance and also included Fuho Capital, with the proceeds intended to fund the research and development of multiple pipeline products.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
26.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Oct 2022 $15M $60M BOC Guangdong Finance ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

GeneBioHealth website traffic

Latest recorded traffic for GeneBioHealth is 320 monthly website visits, down 62.4% over the last three months. GeneBioHealth's team grew 0% over the past year.

Latest monthly visits320 3-month web change-62.4% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
TrueBinding (formally Immutics)An early-stage biotherapeutics development company focused on creating new and exciting molecules for applications Foster City, United States Operational 36 $327M $500M
Gemina LabsDeveloped and patented a transformative bio-chemistry that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals Calgary, Canada Operational
Lyopor3D collagen scaffold for 3D cell culture, suitable for testing the behavior of a wide range of cells in their natural 3D environment Brno, Czechia Operational
Evergreen TheragnosticsContract development and manufacturing of therapeutic radiopharmaceuticals Jersey City, United States Acquired
NuGen Medical DevicesAn emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies Toronto, Canada Operational
AC BioscienceA clinical stage biotech company focused on novel approaches to provide more effective treatments for solid tumor cancer patients Ecublens, Switzerland Operational
Sapreme TechnologieDevelops new technologies within the field of macromolecule therapeutics such as antibody-drug conjugates and oligonucleotide-based therapeutics Driebergen-Rijsenburg, Netherlands Operational
CerecinHealthcare company that develops a novel evidence-based therapeutics, and products that aim to help people Denver, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

GeneBioHealth in the Shenzhen ecosystem

Live from Dealroom

The GeneBioHealth office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • BOC Guangdong Finance
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Shenzhen HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GeneBioHealth on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GeneBioHealth’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.